Indian generic manufacturer Emcure Ltd has announced the production and availability of a heat-stable formulation of ritonavir called Empetus.

Emcure has produced other genetic ARVs, including atazanavir under voluntary license from BMS, which has recently been introduced.

Empetus is available in bottles of 30 tablets costing about $20 per month and still requires WHO pre-qualification.

This generic formulation has been produced prior to a heat stable version of ritonavir from Abbott.

Emcure Pharmaceuticals Ltd.
http://www.emcureaidsinfo.com